Myelodysplastic–myeloproliferative diseases
Group of diseases
| Myelodysplastic–myeloproliferative diseases | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | N/A |
| Pronounce | N/A |
| Field | Hematology |
| Symptoms | Fatigue, anemia, splenomegaly, fever |
| Complications | Acute myeloid leukemia, bone marrow failure |
| Onset | |
| Duration | |
| Types | Chronic myelomonocytic leukemia, Atypical chronic myeloid leukemia, Juvenile myelomonocytic leukemia |
| Causes | |
| Risks | |
| Diagnosis | Blood test, bone marrow biopsy |
| Differential diagnosis | |
| Prevention | N/A |
| Treatment | Chemotherapy, stem cell transplant |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Myelodysplastic–myeloproliferative diseases (MDS/MPN) are a group of hematologic disorders characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). These diseases are marked by the abnormal growth and development of blood cells in the bone marrow, leading to a combination of cytopenias and cytoses.
Classification[edit]
Myelodysplastic–myeloproliferative diseases are classified into several subtypes, including:
- Chronic myelomonocytic leukemia (CMML)
- Atypical chronic myeloid leukemia (aCML)
- Juvenile myelomonocytic leukemia (JMML)
- Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U)
Symptoms[edit]
Common symptoms of MDS/MPN include:
Complications[edit]
Patients with MDS/MPN are at risk for developing:
Diagnosis[edit]
Diagnosis of MDS/MPN typically involves:
- Blood tests to evaluate blood cell counts and morphology
- Bone marrow biopsy to assess the cellularity and presence of dysplastic or proliferative features
Treatment[edit]
Treatment options for MDS/MPN may include:
Related Pages[edit]
- Hematology
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
- Chronic myelomonocytic leukemia
- Atypical chronic myeloid leukemia
- Juvenile myelomonocytic leukemia
- Acute myeloid leukemia
- Bone marrow biopsy
This article is a hematology stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
